We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Suppression Algorithm Reduces Atrial Fibrillation

By HospiMedica staff writers
Posted on 04 Jun 2003
The results of a multicenter clinical trial involving patients with paroxysmal atrial fibrillation (brief episodes of AF) and a class I or II pacemaker indication showed that a pacemaker incorporating new technology called AF Suppression algorithm can reduce the AF burden by 50%. More...
When atrial leads are placed in the low atrial septum, the burden is reduced by almost 72%. These findings were presented at the annual meeting of the North American Society of Pacing and Electrophysiology in Washington, DC (USA).

Historical approaches to AF have centered on pharmacologic therapy, but recent research has shown that pacing therapy can benefit some patients. The new AF Suppression algorithm is designed to continuously monitor intrinsic atrial activity and stimulate the atrium slightly above the patient's intrinsic rhythm in an attempt to control the atrium, thereby suppressing the onset of paroxysmal and persistent AF (longer episodes) and their associated symptoms. The AF Suppression algorithm was developed by St. Jude Medical (St. Paul, MN, USA).

"Suppression pacing alone has already been proven clinically effective and even better results can be expected when the algorithm is used in patients with low atrial septal leads,” said principal investigator Willem De Voogt, M.D., of the St. Lucas Andreas Hospital in Amsterdam (The Netherlands).




Related Links:
St. Jude Medical

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.